Vion (formerly Oncorx) interesting play on Gene Therapy Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vion (formerly Oncorx) interesting play on Gene Therapy

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jim Oravetz who wrote (301)	10/21/2003 1:18:45 PM
From: Jim Oravetz	Read Replies (1) of 370

Vion Licenses Triapine Rights In China, Taiwan, Hong Kong And Macao DOW JONES NEWSWIRES NEW HAVEN, Conn. -- Vion Pharmaceuticals Inc. (VION) has entered into a license agreement with Beijing Pason Pharmaceuticals, Inc. related to Vion's Triapine drug. In a press release, the company said granted Beijing Pason the exclusive rights to develop, manufacture and market Triapine for anticancer and antiviral uses in China, Taiwan, Hong Kong and Macao. It said the agreement requires final approval from various government agencies in China. The terms of the agreement include an initial payment of $500,000 on receipt of required approvals, $4.75 million in additional milestone payments, and royalty payments of 11% of any Triapine revenues in this territory. Pason will fund the preclinical and clinical development necessary for regulatory approval of Triapine in this area. According to Chinese health officials, there are 1 million people infected with human immunodeficiency virus (HIV), 20 million chronic hepatitis B patents and 4.5 million cancer patients. As well, 2 million new cancer patients are diagnosed every year. Vion is a biopharmaceutical company developing novel agents for the treatment of cancer. Company Web Site: vionpharma.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next